Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Species-Dependent Functionality of the Human Cytolytic Fusion Proteins Granzyme B-H22(scFv) and H22(scFv)-Angiogenin in Macrophages

Published:2013-01-11 Issue:4 Volume:2 Page:9-18
ISSN:2073-4468
Container-title:Antibodies
language:en
Short-container-title:Antibodies

Author:

Schiffer Sonja,Hristodorov Dmitrij,Mladenov Radoslav,Aslanian Eric,Huhn Michael,Fischer Rainer,Barth Stefan,Thepen Theo

Publisher

MDPI AG

Subject

Drug Discovery,Immunology,Immunology and Allergy

Link

http://www.mdpi.com/2073-4468/2/1/9/pdf

Reference36 articles.

1. Recombinant toxins for the treatment of cancer;Kreitman;Curr. Opin. Mol. Ther.,2003

2. Ligand-targeted therapeutics in anticancer therapy

3. Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic

4. Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

5. Anti-cancer activity of anti-p185HER-2ricin A chain immunotoxin on gastric cancer cells

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases;Biomedicines;2017-09-12

2. Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation;Biomedicines;2017-02-17

3. Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages;IMMUNOL CELL BIOL;2016

4. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor;Cancer Letters;2016-05

5. Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo;Cancer Immunology, Immunotherapy;2015-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3